![Spacer](https://webarchive.library.unt.edu/eot2008/20090512090114im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |
![Spacer](https://webarchive.library.unt.edu/eot2008/20090512090114im_/http://www.fda.gov/cvm/Images/dot_clear.gif)
Table of Contents
|
![Spacer](https://webarchive.library.unt.edu/eot2008/20090512090114im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |
![Spacer](https://webarchive.library.unt.edu/eot2008/20090512090114im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |
-
Regulatory Issues In Agricultural Biotechnology – FDA Veterinarian – January/February 1998
-
Docket No. 00D-1598, CFSAN 123. Draft Guidance for Industry: Voluntary Labeling Indicating Whether Foods Have or Have Not Been Developed Using Bioengineering; Availability. Pages 4839-4842 [FR Doc. 01-1047] January 18, 2001| html | | pdf | Written comments by March 19, 2001 Written comments on information collection by March 19, 2001
-
FDA to Strengthen Pre-Market Review of Bioengineered Foods – HHS News– May 3, 2000
-
Update on Biotech Plants – FDA Veterinarian – January/February 1997
-
FDA Review of Biotech Plants – FDA Veterinarian – September/October 1999
-
Draft Guidance for Industry #153: Drugs, Biologics, and Medical Devices Derived From Bioengineered Plants for Use in Humans and Animals, September 2003
-
Vol. 67 (September 12, 2002): Docket No. 02D-0324, CBER 200134. Draft Guidance for Industry: Drugs, Biologics, and Medical Devices Derived From Bioengineered Plants for Use in Humans and Animals; Availability. Pages 57828--57829 [FR Doc. 02-23105] | htm | pdf | Comments January 10, 2003 Comment period extended to February 7, 2003
The Draft Guidance Comment extension approval
Web Page Updated by hd - September 18, 2008, 9:23 AM ET
|
![Spacer](https://webarchive.library.unt.edu/eot2008/20090512090114im_/http://www.fda.gov/cvm/Images/dot_clear.gif) |